[The influence of desloratadine on course of intermittens allergic rhinitis].
Influence of desloratadine (DL) therapy on intermittens allergic rhinitis was presented. Investigated group consisted of 60 patients, aged average 29, among them 23 women and 37 men. Score of nasal symptoms as discharge congestion, itching, sneezing and eye symptoms was evaluated. All measurements of nose airways resistance were performed by means of rhinomanometer Rhinotest 1000 (MES). The result was a significant statistic improvement both of separate nasal or eye symptoms, total nasal symptom score and global therapeutic assessments of response to DL therapy. At the beginning the investigation a statistically significant improvement after DL therapy was shown by rhinomanometry among patients with severe or moderate nasal resistance in contrast to low nasal resistance group.
Buczyłko
Krzysztof
K
NZOZ Centrum Alergologii. buczylko@centrum-alergologii.lodz.pl
Chwała
Cezary
C
Zielińska-Bliźniewska
Hanna
H
Wagner
Aneta
A
Dzwonnik
Anna
A
D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D003233:Conjunctivitis, Allergic / Q000150:complications / Q000188:drug therapy; D018450:Disease Progression; D005260:Female; D039563:Histamine H1 Antagonists, Non-Sedating / Q000627:therapeutic use*; D006801:Humans; D017336:Loratadine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D014663:Nasal Decongestants / Q000627:therapeutic use*; D015508:Nasal Obstruction / Q000150:complications / Q000188:drug therapy*; D006255:Rhinitis, Allergic, Seasonal / Q000150:complications / Q000188:drug therapy*; D025363:Rhinomanometry / Q000379:methods / Q000706:statistics & numerical data; D012912:Sneezing / Q000187:drug effects; D011795:Surveys and Questionnaires; D016896:Treatment Outcome
D039563:Histamine H1 Antagonists, Non-Sedating; D014663:Nasal Decongestants; D017336:Loratadine; C121345:desloratadine